Tyler McGinnis
Family Medicine · Yukon, OKNPI 1982349536
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Amgen at 31.3% of the total. 2025 is the largest year on record at $884, 4.3 times the $205 reported in 2022.
Across 42 payments — averaging $54.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$713
- Otsuka America Pharmaceutical, Inc.$220
- AbbVie$158
- Convatec Inc.$148
- Heron Therapeutics, Inc.$122
- Reprise Biomedical, Inc.$120
- plus $794 from 18 others
What the payments were for
- Food & beverage$2,274100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 10 | $713 |
| Otsuka America Pharmaceutical, Inc. | 2 | $220 |
| AbbVie | 2 | $158 |
| Convatec Inc. | 1 | $148 |
| Heron Therapeutics, Inc. | 1 | $122 |
| Reprise Biomedical, Inc. | 1 | $120 |
| Globus Medical | 1 | $115 |
| Medtronic | 1 | $111 |
| Hologic Sales And Service, LLC | 1 | $106 |
| Lilly USA, LLC | 4 | $98 |
| Shield Therapeutics Inc | 2 | $61 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| GSK | 2 | $34 |
| AstraZeneca | 2 | $33 |
| Radius Health, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Next Science LLC | 1 | $22 |
| Abbott | 1 | $21 |
| Exact Sciences | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
| Bayer | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,274 in reported general payments places this provider in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 47 | $264 |
| Levothyroxine Sodium | 21 | $217 |
| Gabapentin | 22 | $194 |
| Carvedilol | 18 | $139 |
| Omeprazole | 11 | $116 |
| Lisinopril | 32 | $115 |
| Amlodipine Besylate | 12 | $94 |
| Montelukast Sodium | 16 | $68 |
| Metformin Hcl | 17 | $52 |
| Hydrochlorothiazide | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Yukon
- Marion StudebakerYukon$13K
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Lisa ConneryNorman$105K
- Michael RobinsonElk City$84K
- Kimberly HuttonTulsa$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.